These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15800922)

  • 1. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
    Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
    Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
    Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
    J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Czernichow S; Hercberg S
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2269-72. PubMed ID: 16172243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study.
    Hercberg S; Kesse-Guyot E; Druesne-Pecollo N; Touvier M; Favier A; Latino-Martel P; Briançon S; Galan P
    Int J Cancer; 2010 Oct; 127(8):1875-81. PubMed ID: 20104528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
    Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
    Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy Aging 5 Years After a Period of Daily Supplementation With Antioxidant Nutrients: A Post Hoc Analysis of the French Randomized Trial SU.VI.MAX.
    Assmann KE; Andreeva VA; Jeandel C; Hercberg S; Galan P; Kesse-Guyot E
    Am J Epidemiol; 2015 Oct; 182(8):694-704. PubMed ID: 26374140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
    Galan P; Briançon S; Favier A; Bertrais S; Preziosi P; Faure H; Arnaud J; Arnault N; Czernichow S; Mennen L; Hercberg S
    Br J Nutr; 2005 Jul; 94(1):125-32. PubMed ID: 16115341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations.
    Czernichow S; Couthouis A; Bertrais S; Vergnaud AC; Dauchet L; Galan P; Hercberg S
    Am J Clin Nutr; 2006 Aug; 84(2):395-9. PubMed ID: 16895889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants.
    Hercberg S; Preziosi P; Galan P; Faure H; Arnaud J; Duport N; Malvy D; Roussel AM; Briançon S; Favier A
    Food Chem Toxicol; 1999; 37(9-10):925-30. PubMed ID: 10541446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.
    Briançon S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S
    Int J Epidemiol; 2011 Dec; 40(6):1605-16. PubMed ID: 22158670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
    Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
    Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
    Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
    Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Briançon S
    Arch Intern Med; 2004 Nov; 164(21):2335-42. PubMed ID: 15557412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of prostate cancer in a randomized clinical trial of calcium supplementation.
    Baron JA; Beach M; Wallace K; Grau MV; Sandler RS; Mandel JS; Heber D; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):586-9. PubMed ID: 15767334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Klein EA; Thompson IM; Tangen CM; Crowley JJ; Lucia MS; Goodman PJ; Minasian LM; Ford LG; Parnes HL; Gaziano JM; Karp DD; Lieber MM; Walther PJ; Klotz L; Parsons JK; Chin JL; Darke AK; Lippman SM; Goodman GE; Meyskens FL; Baker LH
    JAMA; 2011 Oct; 306(14):1549-56. PubMed ID: 21990298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
    Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM
    J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.
    Hercberg S; Galan P; Preziosi P; Roussel AM; Arnaud J; Richard MJ; Malvy D; Paul-Dauphin A; Briançon S; Favier A
    Int J Vitam Nutr Res; 1998; 68(1):3-20. PubMed ID: 9503043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial.
    Kesse-Guyot E; Fezeu L; Jeandel C; Ferry M; Andreeva V; Amieva H; Hercberg S; Galan P
    Am J Clin Nutr; 2011 Sep; 94(3):892-9. PubMed ID: 21775560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.